-
公开(公告)号:US06914158B2
公开(公告)日:2005-07-05
申请号:US10815375
申请日:2004-04-01
申请人: Ronald Keith Webber , Richard C. Durley , Alok K. Awasthi , Arija A. Bergmanis , Kam F. Fok , Scott S. Ganser , Timothy J. Hagen , E. Ann Hallinan , Donald W. Hansen, Jr. , Brian S. Hickory , Pamela T. Manning , Michael Mao , Alan E. Moormann , Barnett S. Pitzele , Michelle A. Promo , Richard R. Schartman , Jeffrey A. Scholten , Jeffrey S. Snyder , Mihaly V. Toth , Mahima Trivedi , Sofya Tsymbalov , Foe Siong Tjoeng
发明人: Ronald Keith Webber , Richard C. Durley , Alok K. Awasthi , Arija A. Bergmanis , Kam F. Fok , Scott S. Ganser , Timothy J. Hagen , E. Ann Hallinan , Donald W. Hansen, Jr. , Brian S. Hickory , Pamela T. Manning , Michael Mao , Alan E. Moormann , Barnett S. Pitzele , Michelle A. Promo , Richard R. Schartman , Jeffrey A. Scholten , Jeffrey S. Snyder , Mihaly V. Toth , Mahima Trivedi , Sofya Tsymbalov , Foe Siong Tjoeng
IPC分类号: A61P1/00 , A61K31/198 , A61K31/4166 , A61K31/4245 , A61P1/02 , A61P1/04 , A61P1/16 , A61P3/00 , A61P3/08 , A61P3/10 , A61P7/06 , A61P9/00 , A61P9/02 , A61P9/10 , A61P11/00 , A61P11/02 , A61P11/06 , A61P13/12 , A61P15/00 , A61P15/08 , A61P17/00 , A61P17/02 , A61P17/06 , A61P19/02 , A61P19/04 , A61P19/06 , A61P21/00 , A61P21/04 , A61P25/00 , A61P25/04 , A61P25/06 , A61P25/10 , A61P25/14 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P25/30 , A61P25/32 , A61P25/34 , A61P25/36 , A61P27/02 , A61P27/06 , A61P29/00 , A61P31/00 , A61P35/00 , A61P37/02 , A61P37/06 , A61P39/02 , A61P43/00 , C07C317/48 , C07C317/50 , C07C323/58 , C07C323/59 , C07D233/76 , C07D271/06 , C07D271/07 , C07D277/56 , C07C323/00
CPC分类号: C07D271/07 , C07C317/48 , C07C323/58 , C07C323/59 , C07D233/76 , C07D277/56
摘要: The present invention relates to amidino compounds and salts and prodrugs thereof. In another embodiment the present invention also provides a use of the present compounds in therapy, particular as nitric oxide synthase inhibitors. In a further embodiment, the present invention provides methods of making the amidino compounds.
摘要翻译: 本发明涉及脒基化合物及其盐和前药。 在另一个实施方案中,本发明还提供本发明化合物在治疗中的用途,特别是作为一氧化氮合酶抑制剂。 在另一个实施方案中,本发明提供了制备脒基化合物的方法。
-
公开(公告)号:US06489323B1
公开(公告)日:2002-12-03
申请号:US09329583
申请日:1999-06-10
申请人: Donald W. Hansen, Jr. , R. Keith Webber , E. Ann Hallinan , Mihaly V. Toth , Barnett S. Pitzele , Alok K. Awasthi , Alan E. Moormann , Suzanne Metz , Jeffery S. Snyder , William M. Moore , Jeffrey A. Scholten
发明人: Donald W. Hansen, Jr. , R. Keith Webber , E. Ann Hallinan , Mihaly V. Toth , Barnett S. Pitzele , Alok K. Awasthi , Alan E. Moormann , Suzanne Metz , Jeffery S. Snyder , William M. Moore , Jeffrey A. Scholten
IPC分类号: C07D49804
CPC分类号: C07D487/04 , C07D513/04 , C07D515/04 , C07F9/6561
摘要: The current invention relates to compounds of Formula I pharmaceutical compositions and methods of use as nitric oxide synthase inhibitors, wherein the substituents are defined in the application.
摘要翻译: 本发明涉及式I药物组合物的化合物和用作一氧化氮合酶抑制剂的方法,其中取代基在本申请中定义。
-
3.
公开(公告)号:US6011028A
公开(公告)日:2000-01-04
申请号:US913838
申请日:1998-03-27
申请人: Donald W. Hansen, Jr. , E. Ann. Hallinan , Timothy J. Hagen , Steven W. Kramer , Suzanne Metz , Karen B. Peterson , Dale P. Spangler , Mihaly V. Toth , Kam F. Fok , Arija A. Bergmanis , R. Keith Webber , Mahima Trivedi , Foe S. Tjoeng , Barnett S. Pitzele
发明人: Donald W. Hansen, Jr. , E. Ann. Hallinan , Timothy J. Hagen , Steven W. Kramer , Suzanne Metz , Karen B. Peterson , Dale P. Spangler , Mihaly V. Toth , Kam F. Fok , Arija A. Bergmanis , R. Keith Webber , Mahima Trivedi , Foe S. Tjoeng , Barnett S. Pitzele
IPC分类号: C07D319/06 , A61K31/045 , A61K31/12 , A61K31/15 , A61K31/165 , A61K31/19 , A61K31/35 , A61K31/351 , A61K31/357 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/42 , A61K31/443 , A61K31/4433 , A61K31/445 , A61K31/451 , A61K31/55 , A61P9/00 , A61P25/00 , A61P25/30 , A61P29/00 , A61P43/00 , C07C251/44 , C07D207/22 , C07D211/72 , C07D211/76 , C07D223/10 , C07D223/12 , C07D225/02 , C07D309/06 , C07D333/16 , C07D333/20 , C07D401/06 , C07D403/06 , C07D405/06 , C07D409/06 , C07D409/14 , C07D413/06 , C07D417/06 , C07D521/00 , C07D267/06 , A61K31/33 , A61K31/395 , C07D281/02
CPC分类号: C07D249/08 , C07D207/22 , C07D211/72 , C07D223/12 , C07D225/02 , C07D231/12 , C07D233/56 , C07D401/06 , C07D403/06 , C07D405/06 , C07D409/06 , C07D409/14 , C07D413/06 , C07D417/06
摘要: The current invention discloses useful amidino derivative useful as nitric oxide synthase inhibitors.
摘要翻译: PCT No.PCT / US96 / 05315 Sec。 371日期:1998年3月27日 102(e)1998年3月27日PCT 1996年4月19日PCT PCT。 出版物WO96 / 33175 日期1996年10月24日本发明公开了可用于一氧化氮合酶抑制剂的有用的脒基衍生物。
-
公开(公告)号:US4523020A
公开(公告)日:1985-06-11
申请号:US550334
申请日:1983-11-10
IPC分类号: C07C205/37 , C07D233/22 , C07D307/33
CPC分类号: C07D307/33 , C07C205/37 , C07D233/22
摘要: This invention relates to novel substituted 2-(3-aminophenoxymethyl)imidazolines which are useful for the treatment of diarrhea and useful as analgesics.
摘要翻译: 本发明涉及可用于治疗腹泻并用作止痛剂的新型取代的2-(3-氨基苯氧基甲基)咪唑啉。
-
5.
公开(公告)号:US4431802A
公开(公告)日:1984-02-14
申请号:US324244
申请日:1981-11-23
IPC分类号: C07C217/62 , C07D233/68 , C07D233/88 , C07D263/32 , C07D263/48 , C07D277/26 , C07D307/52 , C07D307/64 , C07D319/18 , C07D239/24
CPC分类号: C07D307/52 , C07C217/62 , C07D233/68 , C07D233/88 , C07D263/32 , C07D263/48 , C07D277/26 , C07D307/64 , C07D319/18
摘要: Compounds of formula I and salts thereof which are orally pharmacologically active as inhibitors of gastric secretion are disclosed.
摘要翻译: 公开了作为胃分泌抑制剂口服药理学活性的式I化合物及其盐。
-
-
7.Methods of making amidino compounds useful as nitric oxide synthase inhibitors 有权
标题翻译: 制备脒基化合物可用作一氧化氮合酶抑制剂的方法公开(公告)号:US07102013B2
公开(公告)日:2006-09-05
申请号:US10321969
申请日:2002-12-17
申请人: Ronald Keith Webber , Richard C. Durley , Alok K. Awasthi , Arija A. Bergmanis , Kam F. Fok , Scott S. Ganser , Timothy J. Hagen , E. Ann Hallinan , Donald W. Hansen, Jr. , Brian S. Hickory , Pamela T. Manning , Michael Mao , Alan E. Moormann , Barnett S. Pitzele , Michelle A. Promo , Richard R. Schartman , Jeffrey A. Scholten , Jeffrey S. Snyder , Mihaly V. Toth , Mahima Trivedi , Sofya Tsymbalov , Foe Siong Tjoeng
发明人: Ronald Keith Webber , Richard C. Durley , Alok K. Awasthi , Arija A. Bergmanis , Kam F. Fok , Scott S. Ganser , Timothy J. Hagen , E. Ann Hallinan , Donald W. Hansen, Jr. , Brian S. Hickory , Pamela T. Manning , Michael Mao , Alan E. Moormann , Barnett S. Pitzele , Michelle A. Promo , Richard R. Schartman , Jeffrey A. Scholten , Jeffrey S. Snyder , Mihaly V. Toth , Mahima Trivedi , Sofya Tsymbalov , Foe Siong Tjoeng
IPC分类号: C07D233/40 , C07C271/00 , C07C323/00
CPC分类号: C07D271/07 , C07C317/48 , C07C323/58 , C07C323/59 , C07D233/76 , C07D277/56
摘要: Method of making an alpha-amino acid compound having the structure of Formula 32: comprising treating under hydrolyzing conditions a hydantoin compound having the structure of Formula 33: where the substituents are described herein.
摘要翻译: 制备具有式32结构的α-氨基酸化合物的方法:包括在水解条件下处理具有结构式33的乙内酰脲化合物:其中取代基在本文中描述。
-
公开(公告)号:US06951889B2
公开(公告)日:2005-10-04
申请号:US09953049
申请日:2001-09-15
申请人: Donald W. Hansen, Jr. , Ronald Keith Webber , Barnett S. Pitzele , James Sikorski , Mark A. Massa , Timothy J. Hagen , Margaret Grapperhaus , Lijuan Jane Wang , Arija A. Bergmanis , Steven W. Kramer , E. Ann Hallinan
发明人: Donald W. Hansen, Jr. , Ronald Keith Webber , Barnett S. Pitzele , James Sikorski , Mark A. Massa , Timothy J. Hagen , Margaret Grapperhaus , Lijuan Jane Wang , Arija A. Bergmanis , Steven W. Kramer , E. Ann Hallinan
IPC分类号: C07D265/32 , A61K31/198 , A61P1/02 , A61P1/04 , A61P1/16 , A61P3/10 , A61P9/00 , A61P9/10 , A61P11/00 , A61P11/06 , A61P17/02 , A61P17/06 , A61P19/00 , A61P19/02 , A61P19/08 , A61P21/04 , A61P25/04 , A61P25/06 , A61P25/28 , A61P27/02 , A61P27/06 , A61P29/00 , A61P35/00 , A61P37/00 , A61P43/00 , C07C229/30 , C07C237/16 , C07C257/14 , C07C259/14 , C07C271/22 , C07D271/06 , C07D271/07 , C07D413/06 , C07F7/18 , A61K31/195 , C07C251/00
CPC分类号: C07D271/07 , C07B2200/07 , C07B2200/09 , C07C229/30 , C07C257/14 , C07C259/14 , C07C271/22 , C07D413/06 , C07F7/1804
摘要: The present invention relates to 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives and their use in therapy, in particular their use as nitric oxide synthase inhibitors.
-
9.Halogenated amidino amino acid deviratives useful as nitric oxide synthase inhibitors 失效
标题翻译: 用作一氧化氮合酶抑制剂的卤代脒基氨基酸去污剂公开(公告)号:US06344483B1
公开(公告)日:2002-02-05
申请号:US09402953
申请日:2000-01-31
申请人: E. Ann Hallinan , Barnett S. Pitzele , Dale P. Spangler , Mihaly V. Toth , R. Keith Webber , Arija A. Bergmanis , Timothy J. Hagen , Sofya Tsymbalov
发明人: E. Ann Hallinan , Barnett S. Pitzele , Dale P. Spangler , Mihaly V. Toth , R. Keith Webber , Arija A. Bergmanis , Timothy J. Hagen , Sofya Tsymbalov
IPC分类号: A61K31195
CPC分类号: C07D333/24 , C07C257/14 , C07C323/58 , C07C2601/02
摘要: The current invention discloses halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors, and pharmaceutically acceptable salts thereof.
摘要翻译: 本发明公开了可用作一氧化氮合酶抑制剂的卤代脒基氨基酸衍生物及其药学上可接受的盐。
-
10.Non-heterocyclic .beta.-phenyl-.alpha.-aminopropionic acid n-phenyl amides for treatment of neurotoxic injury 失效
标题翻译: 用于治疗神经毒性损伤的非杂环β-苯基-α-氨基丙酸n-苯基酰胺公开(公告)号:US6114381A
公开(公告)日:2000-09-05
申请号:US170784
申请日:1998-10-13
IPC分类号: A61K31/395 , A61K31/47 , C07C237/20 , C07D209/08 , C07D215/08 , C07D215/20 , C07D215/26 , C07D225/08 , A61K31/275 , A61K31/165 , C07C229/36 , C07C233/04
CPC分类号: C07D209/08 , A61K31/395 , A61K31/47 , C07C237/20 , C07D215/08 , C07D215/20 , C07D215/26 , C07D225/08
摘要: Compounds, compositions and methods of treatment are described to control brain damage associated with anoxia or ischemia which typically follows stroke, cardiac arrest or perinatal asphyxia. The treatment includes administration of a .beta.-phenyl-.alpha.-aminopropionic acid N phenyl amide compound as an antagonist to inhibit excitotoxic actions at major neuronal excitatory amino acid receptor sites. Compounds of most interest are those of the formula ##STR1## wherein each of R.sup.1 and R.sup.5 is independently selected from hydrido, fluoro, chloro, bromo, methyl and ethyl; wherein R.sup.3 is selected from hydroxy, methoxy, ethoxy, methoxycarbonyloxy, ethoxycarbonyloxy, (2-methylpropoxy)carbonyloxy and (2-propenyloxy) carbonyloxy; wherein each of R.sup.6, R.sup.7 and R.sup.8 is hydrido; wherein each of R.sup.9 and R.sup.10 is independently selected from hydrido, methyl and ethyl; wherein R.sup.11 is one or more groups independently selected from hydrido, fluoro, chloro, hydroxy, methoxy, methyl and ethyl; or a tautomer or enantiomer therefor, or a pharmaceutically-acceptable salt or ester thereof.
摘要翻译: 描述了治疗的化合物,组合物和方法以控制与缺氧或缺血相关的脑损伤,其通常在中风,心脏骤停或围产期窒息之后。 该治疗包括施用β-苯基-α-氨基丙酸N苯基酰胺化合物作为拮抗剂,以抑制主要神经元兴奋性氨基酸受体位点的兴奋性毒性作用。 最感兴趣的化合物是下式的化合物,其中R 1和R 5各自独立地选自氢,氟,氯,溴,甲基和乙基; 其中R3选自羟基,甲氧基,乙氧基,甲氧基羰基氧基,乙氧基羰基氧基,(2-甲基丙氧基)羰基氧基和(2-丙烯氧基)羰基氧基; 其中R6,R7和R8各自为氢; 其中R 9和R 10各自独立地选自氢,甲基和乙基; 其中R 11是一个或多个独立地选自氢,氟,氯,羟基,甲氧基,甲基和乙基的基团; 或其互变异构体或对映异构体,或其药学上可接受的盐或酯。
-
-
-
-
-
-
-
-
-